Boston Scientific Falls on Watchman Headwinds (BSX:NYSE)

Boston Scientific falls on Watchman headwinds (BSX:NYSE)

Boston Scientific (BSX) stock hits a 52-week low as the company highlights a slowdown in demand for its WATCHMAN cardiac implant. Read more here,

Boston Scientific Hits Two-Year Low After Watchman Device Warning

Boston Scientific shares fell about 10% Wednesday after CEO Mike Mahoney warned of weaker demand for its Watchman heart implant. The stock hit $50.60, its lowest in over two years. Mahoney said Watchman sales likely won’t grow from the first to third quarter, citing a shift to combined procedures. The company maintained its full-year organic revenue growth forecast of 6.5% to 8%. The post Boston Scientific Hits Two-Year Low After Watchman Device…